Protein tyrosine phosphatase 1B variant associated with fat distribution and insulin metabolism

Obesity Research

Volumn 13, Issue 5, 2005, Pages 829-834

  Ukkola, Olavi ^a,b   Rankinen, Tuomo ^a   Lakka, Timo ^a,g   Leon, Arthur S ^c   Skinner, James S ^d   Wilmore, Jack H ^e   Rao, D C ^f   Kesaniemi Y A ^b   Bouchard, Claude ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b UNIVERSITY OF OULU   (Finland)

^c UNIVERSITY OF MINNESOTA   (United States)

^d INDIANA UNIVERSITY   (United States)

^e UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Adiposity; Genotype; Insulin sensitivity; Protein tyrosine phosphate 1B

Indexed keywords

CELL SURFACE RECEPTOR; INSULIN; LEPTIN RECEPTOR; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE 1B;

ADIPOSE TISSUE; ARTICLE; BODY COMPOSITION; CAUCASIAN; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INSULIN RESISTANCE; METABOLISM; NEGRO; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; SKINFOLD THICKNESS;

ADIPOSE TISSUE; AFRICAN CONTINENTAL ANCESTRY GROUP; BODY COMPOSITION; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENOTYPE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HETEROZYGOTE; HOMOZYGOTE; HUMANS; INSULIN; INSULIN RESISTANCE; PHENOTYPE; POLYMORPHISM, GENETIC; PROTEIN-TYROSINE-PHOSPHATASE; RECEPTORS, CELL SURFACE; SKINFOLD THICKNESS;

EID: 24344444907     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2005.95     Document Type: Article

References (20)

1. Neel BG, Tonks NK. Protein tyrosine phosphatases in signal transaction. Curr Opin Cell Biol. 1997:9:193-204.
2. Byon JCH, Kusari AB, Kusari J. Protein-tyrosine phosphatase-1 B acts as a negative regulator of insulin signal transduction. Mol Cell Biochem. 1998;182:101-8.
3. Ahmad F, Li PM, Meyerovitch J, Goldstein BJ. Osmotic-loading of neutralizing antibodies demonstrates a role for protein-tyrosine phosphatase IB in negative regulation of the insulin action pathway. J Biol Chem. 1995:270:20503-8.
4. Elchebly M, Payette P, Michaliszyn E, et al. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science. 1999:283: 1544-8.
5. Kaszubska W, Falls HD, Schaefer VG, et al. Protein tyrosine phosphatase l B negatively regulates leptin signaling in a hypothalamic cell line. Mol Celt Endocrinol. 2002:195:109-18.
6. Ahmad F, Azevedo JL, Cortright R, Dohm GL, Goldstein BJ. Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes. J Clin Invest. 1997;100:449-58.
7. Ahmad F, Considine RV, Goldstein BJ. Increased abundance of the receptor-type protein-tyrosine phosphatase LAR accounts for the elevated insulin receptor dephosphorylating activity in adipose tissue of obese human subjects. J Clin Invest. 1995;95:2806-12.
8. Cheung A, Kusari J, Jansen D, Bandyopadhyay D, Kusari A, Bryer-Ash M. Marked impairment of protein tyrosine phosphatase 1B activity in adipose tissue of obese subjects with and without type 2 diabetes mellitus. J Lab Clin Med. 1999; 134:115-23.
9. Forsell PA, Boie Y, Montalibet J, Collins S, Kennedy BP. Genomic characterization of the human and mouse protein tyrosine phosphatase-IB genes. Gene. 2000:260:145-53.
10. Lembertas AV, Pérusse L, Chagnon YC, et al. Identification of an obesity quantitative trait locus on mouse chromo-some 2 and evidence of linkage to body fat and insulin on the human homologous region 20q. J Clin Invest. 1997; 100:1240-7.
11. Ghosh S, Watanabe RM, Valle TT, et al. The Finland United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study: I. An autosomal genome scan for genes that predispose to type 2 diabetes. Am J Hum Genet. 2000:67:1174-85.
12. Echwald SM, Bach H, Vestergaard H, et al. A P387L variant in protein tyrosine phosphatase-IB (FTP-IB) is associated with type 2 diabetes and impaired serine phosphorylation of FTP-1B in vitro. Diabetes. 2002;51:1-6.
13. Di Paola R, Frittitta L, Miscio G, et al. A variation in 3'UTR of hPTPNl increases specific gene expression and associates with insulin resistance. Am J Hum Genet. 2002;70:806-12.
14. Santaniemi M, Ukkola O, Kesaniemi YA. Tyrosine phos-phatase IB and leptin receptor genes and their interaction in type 2 diabetes. J Intern Med. 2004;256:48-55.
15. Rondinone CM, Trevillyan JM, Clampit J, et al. Protein tyrosine phosphatase IB reduction regulates adiposity and expression of genes involved in lipogenesis. Diabetes. 2002; 51:2405-11.
16. McGuire MC, Fields RM, Nyomba BL, et al. Abnormal regulation of protein tyrosine phosphatase activities in skeletal muscle of insulin-resistant humans. Diabetes. 1991;40:939-42.
17. Bouchard C, Leon AS, Rao DC, Skinner JS, Wilmore JH, Gagnon J. The HERITAGE Family Study: aims, design, and measurement protocol. Med Sci Sports Exerc. 1995;27:721-9.
18. Wilmore JH, Stanforth PR, Domenick MA, et al. Reproducibility of anthropometric and body composition measurements: The HERITAGE Family Study. Int J Obes Relat Metab Disord. 1997;21:297-303.
19. Hong Y, Weisnagel SJ, Rice T, et al. Familial resemblance for glucose and insulin metabolism indices derived from an intravenous glucose tolerance test in blacks and whites of the HERITAGE Family Study. Clin Genet. 2001;60:22-30.
20. Chagnon YC, Chung WK, Pérusse L, Chagnon M, Leibel RL, Bouchard C. Linkages and associations between the leptin receptor (LepR) gene and human body composition in the Quebec Family Study. Int J Obes. 1999;23:278-86.